Prostate News and Research

RSS

Determining the risk of ovarian malignancy in postmenopausal women with abnormal findings in the PLCO screening trial

Reporting on the largest study of its kind today at the Society of Gynecologic Oncologists 37th Annual Meeting on Women's Cancer, researchers presented new criteria for detecting ovarian cancer malignancy in postmenopausal asymptomatic women, 55 to 74 years old.

28 Mar 2006

Why do men choose one prostate treatment over another?

Men with prostate cancer generally make treatment decisions based on differences in the information they receive rather than their own preferences, according to a new review.

27 Mar 2006

Benefit of fish oils under question

In a turn up for the books, experts are now saying that contrary to the widely held belief that the omega 3 fats found in oily fish help prevent heart disease, this has not been proven.

26 Mar 2006

Salvage radiation therapy for PSA recurrence following radical prostatectomy

Salvage radiation therapy to the prostatic fossa is often employed in patients with rising PSA after radical prostatectomy (RP). Interestingly, only 25% of men with rising PSA after RP have a positive prostatic fossa biopsy, yet 70% of men with a negative biopsy will have their PSA decline to undetectable levels following salvage external beam radiotherapy.

23 Mar 2006

Raloxifene shows potential benefits in treating prostate cancer

In a study to be published in the April, 2006 issue of the British Journal of Urology International, researchers at Cedars-Sinai Medical Center have shown that Raloxifene, a drug commonly used to treat osteoporosis, has a potential clinical benefit in treating men with prostate cancer.

23 Mar 2006

Delayed prostate cancer intervention in low risk patients may not decrease ultimate chance for cure

A contemporary discussion exists whether patients with low-risk prostate cancer (CaP) are being overtreated with local treatment modalities. This is due to a combination of the older population affected and the slow doubling time of CaP.

23 Mar 2006

Environmental chemicals implicated in cancer

New research at the University of Liverpool suggests that environmental contaminants, such as pesticides, are more influential in causing cancer than previously thought.

21 Mar 2006

New research suggests it may be possible to separate the anticancer properties of vitamin D

At the right dose, vitamin D is important for bone development and may help protect against the development of several cancers, particularly colorectal cancer.

21 Mar 2006

Pesticides more influential in causing cancer than previously thought

New research at the University of Liverpool suggests that environmental contaminants, such as pesticides, are more influential in causing cancer than previously thought.

20 Mar 2006

Prostate cancer detected on repeat biopsies have more favorable tumor characteristics but similar recurrence rates

Prostate cancer (CaP) detected on repeat biopsy may reflect smaller volume tumors and less aggressive biological and clinical disease.

17 Mar 2006

Chillies send prostate cancer cells on a suicidal path

According to new research the very ingredient which makes chilli peppers so hot, also affects prostate cancer cells and makes them commit suicide.

16 Mar 2006

Low PSA score after radiation can predict prostate cancer return

A consortium of prostate cancer experts have discovered, through a clinical investigation, that prostate cancer patients who have a lower prostate specific antigen (PSA) score after radiation therapy to treat their cancer are less likely to have their prostate cancer return or spread to other parts of their body than patients with a higher PSA score.

15 Mar 2006

Capsaicin drives prostate cancer cells to kill themselves

Capsaicin, the stuff that turns up the heat in jalapeqos, not only causes the tongue to burn, it also drives prostate cancer cells to kill themselves, according to studies published in the March 15 issue of Cancer Research.

15 Mar 2006

New vaccines will protect against cancer

The leading cancer charity in Britain is predicting that thousands of cancers will be prevented every year as specific vaccines are developed.

13 Mar 2006

New method for examining how radiation damages body tissue

The knowledge may make it possible to reduce side effects for cancer patients or to develop treatments for radiation exposure.

1 Mar 2006

Delayed surgical treatment may combat overtreatment of prostate cancer

Delayed surgical treatment for patients with small, low-grade prostate cancer tumors was not associated with lowered curability, according to a study in the March 1 issue of the Journal of the National Cancer Institute.

1 Mar 2006

$Hormone therapy for advanced prostate cancer can lead to bone loss and fractures$

Hormone therapy for advanced prostate cancer can lead to bone loss and fractures

A common type of treatment used to protect bone density in menopausal women is also an effective therapy for advanced prostate cancer patients during the first year of hormone therapy, according to a new Oregon Health & Science University Cancer Institute study.

1 Mar 2006

Ginkgo biloba reduces aggressive cancer risk in animal experiments

Researchers at Georgetown University Medical Center say they now have a clearer picture of how an extract from the leaves of the Ginkgo biloba tree reduces the risk of aggressive cancer in animal experiments.

27 Feb 2006

Study shows survival advantage for men treated with radical prostatectomy or radiation therapy compared to observation

A new study shows older men with early stage prostate cancer survive longer if they are treated versus not being treated in favor of the "watchful waiting" approach advocated by many physicians for older men with other health problems.

27 Feb 2006

Oral agent alendronate may help men with prostate cancer suffering from bone loss

Men with prostate cancer who experience bone loss from cancer treatment could benefit from a weekly oral therapy commonly given to women with osteoporosis, according to a study presented by the University of Pittsburgh Medical Center (UPMC) at the American Society of Clinical Oncology Prostate Cancer Symposium, Feb. 24 to 26 at the San Francisco Marriott.

27 Feb 2006